Jesmond Dalli is a Reader in Molecular Pharmacology at the Barts and The London School of Medicine and Dentistry and Queen Mary College. He is also a Sir Henry Dale Fellow and the director of the Lipid Mediator Unit at the William Harvey Research Institute. He received a B.Sc (Hons) in chemistry and biology and an M.Sc in biology from the University of Malta. He then read for and completed a Ph.D at the William Harvey Research Institute, Queen Mary University of London with Prof. Mauro Perretti. Dr. Dalli then moved to Prof. Charles N. Serhan’s laboratory at Harvard Medical school and the Brigham and Women’s Hospital where he held the position of Instructor. He was also the co-director with Prof. Serhan of two NIH funded lipid mediator metabololipidomics cores. He published over 100 peer-reviewed publications including publications in Nature Medicine, Immunity and Science Translation Medicine. He is the recipient of several awards and honors including the William Harvey Young Investigator award and the IADR/AADR William J. Gies Award. His research efforts are focused on the structural elucidation of omega-3 polyunsaturated fatty acid-derived bioactive lipid mediators, assessing their cellular targets and the molecular mechanisms through which these mediators exert their actions in the resolution of inflammation.